Yidan Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yidan Sun has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Jiang Tan
Department of Genetics, Washington University School of Medicine , St. Louis, MO
3 shared publications- Asifa Akhtar
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
2 shared publications - Jiang Tan
Institute of Virology, University Medical Center, and Faculty of Medicine, Albert-Ludwig-University Freiburg, Freiburg, Germany
2 shared publications - Maria Shvedunova
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
2 shared publications Nahyun Kong
Washington University
2 shared publications- Niyazi Umut Erdogdu
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (8)
NextLongIso: a comprehensive Nextflow pipeline for multi-dimensional long-read RNA-seq analysis
Summary: Long-read RNA sequencing technologies, including Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), enable direct characterization of full-length transcripts and transcriptome complexity. However, analysis of long-read RNA-seq data remains fragmented across multiple tools, limiting the ability to obtain a unified view of transcript structure, expression, and regulatory variation in long-read transcriptomes. We present NextLongIso, a scalable and reproducible Nextflow pipeline that enables coordinated analysis of multiple layers of transcript regulation. Rather than focusing solely on transcript reconstruction, NextLongIso integrates transcript discovery with downstream regulatory analyses to jointly characterize alternative splicing, isoform switching, transcript boundary dynamics (including alternative promoters and polyadenylation), and transposable element-associated transcription from both PacBio and ONT datasets. By eliminating complex cross-tool data harmonization, this unified framework facilitates the transition from transcript identification to functional interpretation of transcriptomic variation. Availability and Implementation: NextLongIso is implemented in Nextflow and is freely available at github: https://github.com/YidanSunResearchLab/nf-LongIso.git and Zenodo: https://doi.org/10.5281/zenodo.21049837.
- 3 August 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (8)
Open AccessNextLongIso: a comprehensive Nextflow pipeline for multi-dimensional long-read RNA-seq analysis
Summary: Long-read RNA sequencing technologies, including Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), enable direct characterization of full-length transcripts and transcriptome complexity. However, analysis of long-read RNA-seq data remains fragmented across multiple tools, limiting the ability to obtain a unified view of transcript structure, expression, and regulatory variation in long-read transcriptomes. We present NextLongIso, a scalable and reproducible Nextflow pipeline that enables coordinated analysis of multiple layers of transcript regulation. Rather than focusing solely on transcript reconstruction, NextLongIso integrates transcript discovery with downstream regulatory analyses to jointly characterize alternative splicing, isoform switching, transcript boundary dynamics (including alternative promoters and polyadenylation), and transposable element-associated transcription from both PacBio and ONT datasets. By eliminating complex cross-tool data harmonization, this unified framework facilitates the transition from transcript identification to functional interpretation of transcriptomic variation. Availability and Implementation: NextLongIso is implemented in Nextflow and is freely available at github: https://github.com/YidanSunResearchLab/nf-LongIso.git and Zenodo: https://doi.org/10.5281/zenodo.21049837.
- Open Access
- 20 July 2026
- Published by Springer Nature in Research Square
Uniparental Disomy Reveals Hidden Genetic Causes of Congenital Heart Disease
Congenital heart disease (CHD) affects ~1% of live births, yet the genetic basis of many cases remains unresolved. Uniparental disomy (UPD), the inheritance of both homologous chromosomes from one parent, is often overlooked. We developed TrioMix-UPD, an integrated short- and long-read sequencing framework for UPD detection and classification. Applying it to 3,740 CHD trios, we identified 12 UPD events, representing a 6.57-fold enrichment relative to the general population. Both advanced maternal age and enrichment of rare inherited variants in synaptonemal complex genes implicated meiotic chromosome segregation defects in UPD risk. Within UPD regions, we identified pathogenic homozygous variants in PIEZO1 and GLYR1 and nominate MESD as a novel CHD candidate gene. Functional studies in zebrafish and human cells recapitulated patient-specific cardiac phenotypes. Differential methylation analyses implicated imprinting dysregulation, including at the Prader-Willi critical region. Collectively, these findings establish UPD as an underrecognized contributor to CHD.
- 20 July 2026
- Published by Springer Nature in Research Square
Open AccessUniparental Disomy Reveals Hidden Genetic Causes of Congenital Heart Disease
Congenital heart disease (CHD) affects ~1% of live births, yet the genetic basis of many cases remains unresolved. Uniparental disomy (UPD), the inheritance of both homologous chromosomes from one parent, is often overlooked. We developed TrioMix-UPD, an integrated short- and long-read sequencing framework for UPD detection and classification. Applying it to 3,740 CHD trios, we identified 12 UPD events, representing a 6.57-fold enrichment relative to the general population. Both advanced maternal age and enrichment of rare inherited variants in synaptonemal complex genes implicated meiotic chromosome segregation defects in UPD risk. Within UPD regions, we identified pathogenic homozygous variants in PIEZO1 and GLYR1 and nominate MESD as a novel CHD candidate gene. Functional studies in zebrafish and human cells recapitulated patient-specific cardiac phenotypes. Differential methylation analyses implicated imprinting dysregulation, including at the Prader-Willi critical region. Collectively, these findings establish UPD as an underrecognized contributor to CHD.
- Open Access
- 15 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec3865
Transcription initiation drives dosage compensation establishment and maintenance in male Drosophila.
Dosage compensation (DC) in Drosophila equalizes X chromosome-linked gene expression via the male-specific lethal complex, which acetylates histone 4 lysine-16 on the male X chromosome. How DC is established during early embryogenesis remains obscure, largely due to the difficulty of obtaining sufficient sex-specific material at early embryonic stages. Here, we developed a high-throughput embryo sorting strategy and combined newly synthesized RNA-sequencing and RNA polymerase II (Pol II) profiling to investigate the mechanisms underlying the onset of DC in vivo. We found that changes in transcription initiation occur before detectable differences in transcriptional pausing or elongation and represent the primary determinant of enhanced mRNA output during DC establishment. It had hitherto been unclear whether DC establishment and maintenance exerted similar or distinct effects on transcriptional kinetics. Extending genome-wide profiling to S2 cells, we uncovered Pol II initiation as a general principle underlying both inception and perpetuation of DC-driven transcriptional up-regulation.
- 15 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec3865
Open AccessTranscription initiation drives dosage compensation establishment and maintenance in male Drosophila.
Dosage compensation (DC) in Drosophila equalizes X chromosome-linked gene expression via the male-specific lethal complex, which acetylates histone 4 lysine-16 on the male X chromosome. How DC is established during early embryogenesis remains obscure, largely due to the difficulty of obtaining sufficient sex-specific material at early embryonic stages. Here, we developed a high-throughput embryo sorting strategy and combined newly synthesized RNA-sequencing and RNA polymerase II (Pol II) profiling to investigate the mechanisms underlying the onset of DC in vivo. We found that changes in transcription initiation occur before detectable differences in transcriptional pausing or elongation and represent the primary determinant of enhanced mRNA output during DC establishment. It had hitherto been unclear whether DC establishment and maintenance exerted similar or distinct effects on transcriptional kinetics. Extending genome-wide profiling to S2 cells, we uncovered Pol II initiation as a general principle underlying both inception and perpetuation of DC-driven transcriptional up-regulation.
- Open Access
SnakeHichipTF reveals transcription factor logic underlying enhancer-promoter wiring in the human brain
Enhancer-promoter interactions are a central feature of gene regulation, yet the regulatory logic that governs their selective formation in complex tissues remains poorly understood. To address this gap, we developed SnakeHichipTF, a reproducible and scalable framework that integrates multi-engine HiChIP analysis with AI-based footprinting to decode the transcription factor (TF) logic underlying enhancer-promoter wiring. Applying SnakeHichipTF to HiChIP datasets from the human Middle Frontal Gyrus (MFG) and Substantia Nigra (SN), we identified distinct region-biased enhancer interactions associated with differential gene expression. MFG-biased interactions were enriched for cognitive and psychiatric associated GWAS traits, whereas SN-biased interactions preferentially intersected lipid and metabolic trait architectures. Integration of TF footprinting revealed that these region-biased interaction networks are governed by distinct TF programs: MFG-biased interactions preferentially recruited TFs linked to neuronal signaling and transcriptional activation, whereas SN-biased interactions were associated with metabolic and stress-responsive regulators. Interestingly, MFG-biased regulatory interactions were significantly enriched for Human Accelerated Regions (HARs), and HAR-associated genes showed elevated expression in humans relative to non-human primates, indicating that cortical enhancer wiring is embedded within evolutionarily modified regulatory elements. Together, by linking 3D chromatin architecture, TF logic, genetic risk, and evolutionary regulatory elements, SnakeHichipTF provides a general framework for dissecting the mechanistic basis of spatial gene regulation.
Open AccessSnakeHichipTF reveals transcription factor logic underlying enhancer-promoter wiring in the human brain
Enhancer-promoter interactions are a central feature of gene regulation, yet the regulatory logic that governs their selective formation in complex tissues remains poorly understood. To address this gap, we developed SnakeHichipTF, a reproducible and scalable framework that integrates multi-engine HiChIP analysis with AI-based footprinting to decode the transcription factor (TF) logic underlying enhancer-promoter wiring. Applying SnakeHichipTF to HiChIP datasets from the human Middle Frontal Gyrus (MFG) and Substantia Nigra (SN), we identified distinct region-biased enhancer interactions associated with differential gene expression. MFG-biased interactions were enriched for cognitive and psychiatric associated GWAS traits, whereas SN-biased interactions preferentially intersected lipid and metabolic trait architectures. Integration of TF footprinting revealed that these region-biased interaction networks are governed by distinct TF programs: MFG-biased interactions preferentially recruited TFs linked to neuronal signaling and transcriptional activation, whereas SN-biased interactions were associated with metabolic and stress-responsive regulators. Interestingly, MFG-biased regulatory interactions were significantly enriched for Human Accelerated Regions (HARs), and HAR-associated genes showed elevated expression in humans relative to non-human primates, indicating that cortical enhancer wiring is embedded within evolutionarily modified regulatory elements. Together, by linking 3D chromatin architecture, TF logic, genetic risk, and evolutionary regulatory elements, SnakeHichipTF provides a general framework for dissecting the mechanistic basis of spatial gene regulation.
- Open Access
- 1 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
SnakeAltPromoter Facilitates Differential Alternative Promoter Analysis
Background: Alternative promoter usage contributes to isoform diversity and gene regulation in mammals but remains difficult to study at scale. Cap Analysis of Gene Expression precisely maps transcription start sites, but its cost limits large-scale application. Alternatively, ProActiv, Salmon, and DEXSeq can be utilized with widely available RNA sequencing (RNA-seq) data to infer promoter activity. However, there is currently no framework available to automate the generation of reproducible results for these methods. Results: SnakeAltPromoter, a scalable end-to-end Snakemake workflow, has been developed to automate alternative promoter analysis from raw RNA-seq data. The workflow performs quality control, alignment, and promoter quantification using 3 complementary RNA-seq analysis methods (junction-based, transcript-based, and first-exon-based), followed by promoter classification and differential activity or usage analysis. SnakeAltPromoter supports both command-line and graphical user interface usage and utilizes standardized modules to enhance reproducibility. A built-in benchmarking module compares promoter activities inferred from RNA-seq data to matched Cap Analysis of Gene Expression data to evaluate quantification performance. Our analyses revealed robust and complementary performance profiles among the evaluated methods across tissues and cell types, highlighting the value of a unified framework for promoter analysis. Conclusions: To our knowledge, SnakeAltPromoter is the first unified and reproducible framework that combines scalable execution and guided method selection for RNA-seq-based promoter analysis. By standardizing and integrating existing RNA-seq-based promoter analysis tools, it provides researchers with a robust and accessible platform to investigate promoter-level regulation and alternative promoter activity and will enhance the research value of large, public RNA-seq repositories. Code is freely available at https://github.com/YidanSunResearchLab/SnakeAltPromoter.git .
- 1 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
Open AccessSnakeAltPromoter Facilitates Differential Alternative Promoter Analysis
Background: Alternative promoter usage contributes to isoform diversity and gene regulation in mammals but remains difficult to study at scale. Cap Analysis of Gene Expression precisely maps transcription start sites, but its cost limits large-scale application. Alternatively, ProActiv, Salmon, and DEXSeq can be utilized with widely available RNA sequencing (RNA-seq) data to infer promoter activity. However, there is currently no framework available to automate the generation of reproducible results for these methods. Results: SnakeAltPromoter, a scalable end-to-end Snakemake workflow, has been developed to automate alternative promoter analysis from raw RNA-seq data. The workflow performs quality control, alignment, and promoter quantification using 3 complementary RNA-seq analysis methods (junction-based, transcript-based, and first-exon-based), followed by promoter classification and differential activity or usage analysis. SnakeAltPromoter supports both command-line and graphical user interface usage and utilizes standardized modules to enhance reproducibility. A built-in benchmarking module compares promoter activities inferred from RNA-seq data to matched Cap Analysis of Gene Expression data to evaluate quantification performance. Our analyses revealed robust and complementary performance profiles among the evaluated methods across tissues and cell types, highlighting the value of a unified framework for promoter analysis. Conclusions: To our knowledge, SnakeAltPromoter is the first unified and reproducible framework that combines scalable execution and guided method selection for RNA-seq-based promoter analysis. By standardizing and integrating existing RNA-seq-based promoter analysis tools, it provides researchers with a robust and accessible platform to investigate promoter-level regulation and alternative promoter activity and will enhance the research value of large, public RNA-seq repositories. Code is freely available at https://github.com/YidanSunResearchLab/SnakeAltPromoter.git .
- Open Access
PEhub resolves the hierarchical regulatory architecture of multi-way enhancer hubs in the human brain
Chromatin interaction assays capture regulatory architecture as stochastic pairwise contacts, limiting the ability to resolve how multiple enhancers cooperatively regulate transcription. Here we introduce a promoter-centric quantitative framework, termed PEhub, that resolves multi-way enhancer hubs as higher-order regulatory units from chromatin interaction data. By reparameterizing stochastic pairwise ligation events into promoter-conditioned enhancer networks, our approach explicitly models synergistic enhancer cooperation while accounting for distance-dependent interaction decay through a statistically principled null model. Using H3K27ac HiChIP data, we identify promoter-anchored enhancer hubs and validate their physical existence with single-molecule Pore-C, demonstrating that inferred hubs correspond to bona fide multi-way chromatin assemblies. Application to six human brain regions reveals that enhancer hubs are associated with elevated transcriptional output and exhibit a hierarchical organization spanning shared, circuit-specific, and region-restricted regulatory programs. This architecture hierarchically stratifies genetic risk and transcription factor deployment, linking three-dimensional genome organization to transcriptional control and disease-associated variation. Together, this promoter-centric framework provides a generalizable strategy for resolving higher-order regulatory architecture from 3D genome data and establishes multi-way enhancer hubs as a functionally and genetically meaningful layer of transcriptional regulation in complex tissues.
Open AccessPEhub resolves the hierarchical regulatory architecture of multi-way enhancer hubs in the human brain
Chromatin interaction assays capture regulatory architecture as stochastic pairwise contacts, limiting the ability to resolve how multiple enhancers cooperatively regulate transcription. Here we introduce a promoter-centric quantitative framework, termed PEhub, that resolves multi-way enhancer hubs as higher-order regulatory units from chromatin interaction data. By reparameterizing stochastic pairwise ligation events into promoter-conditioned enhancer networks, our approach explicitly models synergistic enhancer cooperation while accounting for distance-dependent interaction decay through a statistically principled null model. Using H3K27ac HiChIP data, we identify promoter-anchored enhancer hubs and validate their physical existence with single-molecule Pore-C, demonstrating that inferred hubs correspond to bona fide multi-way chromatin assemblies. Application to six human brain regions reveals that enhancer hubs are associated with elevated transcriptional output and exhibit a hierarchical organization spanning shared, circuit-specific, and region-restricted regulatory programs. This architecture hierarchically stratifies genetic risk and transcription factor deployment, linking three-dimensional genome organization to transcriptional control and disease-associated variation. Together, this promoter-centric framework provides a generalizable strategy for resolving higher-order regulatory architecture from 3D genome data and establishes multi-way enhancer hubs as a functionally and genetically meaningful layer of transcriptional regulation in complex tissues.
- Open Access
- 28 March 2025
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 21 (3) , e1011635
Alternative promoter usage during organ development
Dynamic gene expression is crucial for mammalian organ development, influencing organ-specific functions and responses. A significant number of mammalian protein-coding genes are regulated by multiple distinct promoters, suggesting that the choice of promoter is as critical as its transcriptional output. However, the role of alternative promoters in organ development remains largely unexplored. In this study, we utilized RNA-seq data from 313 mouse samples across various developmental stages in seven major organs to identify active promoters. Our analyses revealed between 967 and 3,237 developmentally dynamic promoters (DDPs) in each organ. These DDPs encompass not only major promoters with the highest activity within a gene but also alternative promoters with lower activity, which are often overlooked in traditional gene-level analyses. Notably, we found that alternative DDPs can be independently regulated compared to their major counterparts, suggesting the involvement of unique transcriptional regulatory mechanisms. Furthermore, we observed that increased alternative promoter usage plays a pivotal role in driving organ-specific functions and gene expression alterations. Our findings underscore the importance of alternative promoter usage in shaping organ identity and function, providing new insights into the regulatory complexity of organogenesis.
- 28 March 2025
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 21 (3) , e1011635
Open AccessAlternative promoter usage during organ development
Dynamic gene expression is crucial for mammalian organ development, influencing organ-specific functions and responses. A significant number of mammalian protein-coding genes are regulated by multiple distinct promoters, suggesting that the choice of promoter is as critical as its transcriptional output. However, the role of alternative promoters in organ development remains largely unexplored. In this study, we utilized RNA-seq data from 313 mouse samples across various developmental stages in seven major organs to identify active promoters. Our analyses revealed between 967 and 3,237 developmentally dynamic promoters (DDPs) in each organ. These DDPs encompass not only major promoters with the highest activity within a gene but also alternative promoters with lower activity, which are often overlooked in traditional gene-level analyses. Notably, we found that alternative DDPs can be independently regulated compared to their major counterparts, suggesting the involvement of unique transcriptional regulatory mechanisms. Furthermore, we observed that increased alternative promoter usage plays a pivotal role in driving organ-specific functions and gene expression alterations. Our findings underscore the importance of alternative promoter usage in shaping organ identity and function, providing new insights into the regulatory complexity of organogenesis.
- Open Access
- 29 November 2023
- Published by Springer Nature in Nature
- Vol. 624 (7990) , 173-181
MSL2 ensures biallelic gene expression in mammals
In diploid organisms, biallelic gene expression enables the production of adequate levels of mRNA1,2. This is essential for haploinsufficient genes, which require biallelic expression for optimal function to prevent the onset of developmental disorders1,3. Whether and how a biallelic or monoallelic state is determined in a cell-type-specific manner at individual loci remains unclear. MSL2 is known for dosage compensation of the male X chromosome in flies. Here we identify a role of MSL2 in regulating allelic expression in mammals. Allele-specific bulk and single-cell analyses in mouse neural progenitor cells revealed that, in addition to the targets showing biallelic downregulation, a class of genes transitions from biallelic to monoallelic expression after MSL2 loss. Many of these genes are haploinsufficient. In the absence of MSL2, one allele remains active, retaining active histone modifications and transcription factor binding, whereas the other allele is silenced, exhibiting loss of promoter–enhancer contacts and the acquisition of DNA methylation. Msl2-knockout mice show perinatal lethality and heterogeneous phenotypes during embryonic development, supporting a role for MSL2 in regulating gene dosage. The role of MSL2 in preserving biallelic expression of specific dosage-sensitive genes sets the stage for further investigation of other factors that are involved in allelic dosage compensation in mammalian cells, with considerable implications for human disease.
- 29 November 2023
- Published by Springer Nature in Nature
- Vol. 624 (7990) , 173-181
Open AccessMSL2 ensures biallelic gene expression in mammals
In diploid organisms, biallelic gene expression enables the production of adequate levels of mRNA1,2. This is essential for haploinsufficient genes, which require biallelic expression for optimal function to prevent the onset of developmental disorders1,3. Whether and how a biallelic or monoallelic state is determined in a cell-type-specific manner at individual loci remains unclear. MSL2 is known for dosage compensation of the male X chromosome in flies. Here we identify a role of MSL2 in regulating allelic expression in mammals. Allele-specific bulk and single-cell analyses in mouse neural progenitor cells revealed that, in addition to the targets showing biallelic downregulation, a class of genes transitions from biallelic to monoallelic expression after MSL2 loss. Many of these genes are haploinsufficient. In the absence of MSL2, one allele remains active, retaining active histone modifications and transcription factor binding, whereas the other allele is silenced, exhibiting loss of promoter–enhancer contacts and the acquisition of DNA methylation. Msl2-knockout mice show perinatal lethality and heterogeneous phenotypes during embryonic development, supporting a role for MSL2 in regulating gene dosage. The role of MSL2 in preserving biallelic expression of specific dosage-sensitive genes sets the stage for further investigation of other factors that are involved in allelic dosage compensation in mammalian cells, with considerable implications for human disease.